Theravance Biopharma Inc

Theravance Biopharma Inc - PE Ratioverified

TBPH

Price:

$16.9

Market Cap:

$875.90M

Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States. It offers YUPELRI, an once-daily, nebulized long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease (COPD); and Ampreloxetine an investigational, once-daily norepinephrine reuptake inhibitor, Which is in Phase 3 clinical trials for symptomatic neurogenic orthostatic hypotension (nOH) in patients with Multiple System Atrophy (MSA). It has a strategic collaboration agreement with Viatris Inc. for the development and commercialization of revefenacin, including YUPELRI inhalation solution. Theravance Biopharma, Inc. was incorporated in 2013 and...[Read more]

Industry

Biotechnology

IPO Date

2014-05-16

Stock Exchange

NASDAQ

Ticker

TBPH

The PE Ratio as of August 2026 (TTM) for Theravance Biopharma Inc (TBPH) is -221.78

According to Theravance Biopharma Inc’s latest financial reports and current stock price. The company's current PE Ratio is -221.78. This represents a change of -5511.63% compared to the average of 4.10 of the last 4 quarters.

Theravance Biopharma Inc (TBPH) Historical PE Ratio (quarterly & annually)

How has TBPH PE Ratio performed in the past?

The mean historical PE Ratio of Theravance Biopharma Inc over the last ten years is -5.24. The current -221.78 PE Ratio has changed 423.48% with respect to the historical average. Over the past ten years (40 quarters), TBPH's PE Ratio was at its highest in in the September 2025 quarter at 52.14. The PE Ratio was at its lowest in in the March 2026 quarter at -42.18.

Quarterly (TTM)
Annual

Average

-5.24

Median

-6.25

Minimum

-11.24

Maximum

8.91

Theravance Biopharma Inc (TBPH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Theravance Biopharma Inc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 143.82%

Maximum Annual PE Ratio = 8.91

Minimum Annual Increase = -208.88%

Minimum Annual PE Ratio = -11.24

Quarterly (TTM)
Annual
YearPE RatioChange
20258.91-208.88%
2024-8.18-27.20%
2023-11.2426.22%
2022-8.90131.28%
2021-3.85-3.37%
2020-3.98-34.60%
2019-6.09-5.02%
2018-6.4125.33%
2017-5.12-31.62%
2016-7.48143.82%

Theravance Biopharma Inc (TBPH) Average PE Ratio

How has TBPH PE Ratio performed in the past?

The current PE Ratio of Theravance Biopharma Inc (TBPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-3.50

5-year avg

-4.65

10-year avg

-5.24

Theravance Biopharma Inc (TBPH) PE Ratio vs. Peers

How is TBPH’s PE Ratio compared to its peers?

Theravance Biopharma Inc’s PE Ratio is less than BlackRock Innovation and Growth Term Trust (0), less than Monte Rosa Therapeutics, Inc. (-8.36), less than Day One Biopharmaceuticals, Inc. (-20.70), less than Geron Corporation (-15.62), less than Replimune Group, Inc. (-3.48), less than Vir Biotechnology, Inc. (-2.91), less than LENZ Therapeutics, Inc. (-1.46), less than ArriVent BioPharma, Inc. (-8.58), less than Valneva SE (-2.75), less than Tyra Biosciences, Inc. (-10.84),

Build a custom stock screener for Theravance Biopharma Inc (TBPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theravance Biopharma Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theravance Biopharma Inc (TBPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theravance Biopharma Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Theravance Biopharma Inc's PE Ratio?

How is the PE Ratio calculated for Theravance Biopharma Inc (TBPH)?

What is the highest PE Ratio for Theravance Biopharma Inc (TBPH)?

What is the 3-year average PE Ratio for Theravance Biopharma Inc (TBPH)?

What is the 5-year average PE Ratio for Theravance Biopharma Inc (TBPH)?

How does the current PE Ratio for Theravance Biopharma Inc (TBPH) compare to its historical average?